Managing Director

0000950123-21-010730.txt : 20210813 0000950123-21-010730.hdr.sgml : 20210813 20210813092401 ACCESSION NUMBER: 0000950123-21-010730 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20210630 FILED AS OF DATE: 20210813 DATE AS OF CHANGE: 20210813 EFFECTIVENESS DATE: 20210813 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MPM Oncology Impact Management LP CENTRAL INDEX KEY: 0001687078 IRS NUMBER: 364818254 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-20107 FILM NUMBER: 211169986 BUSINESS ADDRESS: STREET 1: 450 KENDALL STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 6174259200 MAIL ADDRESS: STREET 1: 450 KENDALL STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 13F-HR 1 primary_doc.xml 13F-HR LIVE 0001687078 XXXXXXXX 06-30-2021 06-30-2021 false MPM Oncology Impact Management LP

450 KENDALL STREET CAMBRIDGE MA 02142

13F HOLDINGS REPORT 028-20107 N Ansbert Gadicke Managing Director (617) 425-9200 /s/Ansbert Gadicke Cambridge MA 08-12-2021 0 14 608713 false INFORMATION TABLE 2 5567.xml INFORMATION TABLE FOR FORM 13F ADC Therapeutics, Inc. Common H0036K147 5309 218027 SH SOLE 218027 0 0 Cullinan Management, Inc. Common 230031106 203783 7913887 SH SOLE 7913887 0 0 Epizyme, Inc. Common 29428V104 19375 2331534 SH SOLE 2331534 0 0 G1 Therapeutics, Inc. Common 3621LQ109 17833 812794 SH SOLE 812794 0 0 Harpoon Therapeutics, Inc. Common 41358P106 44338 3196707 SH SOLE 3196707 0 0 iTeos Therapeutics, Inc. Common 46565G104 59985 2338581 SH SOLE 2338581 0 0 MEI Pharma, Inc. Common 552798202 28893 10137859 SH SOLE 10137859 0 0 Merus N.V. Common N5749R100 14768 700879 SH SOLE 700879 0 0 Oncorus, Inc. Common 68236R103 32803 2377031 SH SOLE 2377031 0 0 Repare Therapeutics, Inc. Common 760273102 52260 1676087 SH SOLE 1676087 0 0 TCR2 Therapeutics, Inc. Common 87808K106 55318 3370982 SH SOLE 3370982 0 0 Turning Point Therapeutics, Inc. Common 90041T108 21002 269186 SH SOLE 269186 0 0 Werewolf Therapeutics, Inc. Common 95075A107 41647 2388011 SH SOLE 2388011 0 0 YmAbs Therapeutics, Inc. Common 984241109 11400 337291 SH SOLE 337291 0 0